PD-1 regulates extrathymic regulatory T-cell differentiation-Reference-Cited by-同舟云学术

PD-1 regulates extrathymic regulatory T-cell differentiation

Published:2014-08-18 Issue:9 Volume:44 Page:2603-2616
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Chen Xiufen¹,Fosco Dominick¹,Kline Douglas E.¹²,Meng Liping¹,Nishi Saki²,Savage Peter A.²,Kline Justin¹²

Affiliation:

1. Department of Medicine; University of Chicago Comprehensive Cancer Center; Chicago IL USA

2. Committee on Immunology; University of Chicago Comprehensive Cancer Center; Chicago IL USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201344423/fullpdf

Reference56 articles.

1. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases;Sakaguchi;J. Immunol.,1995

2. Regulatory T cells and immune tolerance;Sakaguchi;Cell,2008

3. The development and function of regulatory T cells;Workman;Cell. Mol. Life Sci.,2009

4. Control of regulatory T cell development by the transcription factor Foxp3;Hori;Science,2003

5. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3;Bennett;Nat. Genet.,2001

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches;Medical Oncology;2024-06-14

2. PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development;ImmunoHorizons;2024-03-01

3. Targeting CENP-E augments immunotherapy in non-small cell lung cancer via stabilizing PD-L1;International Immunopharmacology;2024-01

4. PD1 is transcriptionally regulated by LEF1 in mature T cells;Immunobiology;2023-09

5. Thymic expression of immune checkpoint molecules and their implication for response to immunotherapies;Trends in Cancer;2023-08